TB can be diagnosed in several ways. Sputum smear microscopy, a primary screening test that is particularly used in endemic areas, is used to examine the presence of bacteria. 4, 5 Even if this technique is rapid and low cost, previous studies have shown that the sensitivity of the test is variable (48%-62%). [6] [7] [8] [9] Conventional culture-based methods, use of a reference standard, permit the growth of bacteria from clinical specimens and can be used to determine the species of Mycobacterium. Nevertheless, these methods are time-consuming due to a requirement of TB growth and can take up to 8 weeks. 10 Molecular diagnostic tests are continually being developed not only to decrease their turnaround time but also to improve the sensitivity of the TB diagnosis. 11, 12 The
Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA), a fully automated, walkaway, real-time PCR-based method with a total turnaround time of approximately 2 hours, has been endorsed by the WHO for simultaneous diagnosis of TB and rifampicin resistance. 13 However, the disadvantages of the Xpert MTB/RIF include its high cost, regular maintenance, stable electric power supply requirement, and limited machine capacity (four tests every 2 hours). 14 Unlike PCR-based assays, isothermal amplification methods avoid the requirements for thermal cycling and specific power supply instruments. 15 Isothermal amplification methods amplify products at a constant temperature, which can be supported with a simple heat block. This method is a major advantage for low-resource settings and can be applied as a point-of-care
test. Several isothermal amplification methods were recently shown to be able to detect Mtb, including transcription-mediated amplification (TMA), loop-mediated amplification (LAMP), and helicase-dependent amplification (HDA). [16] [17] [18] [19] Recombinase polymerase amplification (RPA) has emerged as a novel isothermal amplification method that is useful in many diagnostic fields. 20 The three core enzymes required for the reaction are recombinase, single-stranded binding protein, and DNA polymerase. 21 The amplification process occurs under an optimum temperature that ranges from 37 to 42°C and takes <10-40 minutes. 22, 23 Previous studies have shown successful Mtb detection by the RPA technique via real-time device detection or endpoint detection via bridging flocculation. 24, 25 However, specific devices are required to accomplish these tests.
Hence, in this study, we developed an alternative molecular diagnostic test based on isothermal amplification methods. The aim of this study was to establish an affordable, rapid, and easy hands-on detection tool for Mtb detection, targeting low-resource and peripheral healthcare settings or fieldworks where specific instrumentation is limited. RPA was used to amplify target genes, specifically
Mtb IS6110 and IS1081. Then, SYBR Green I was added after the amplification to observe the RPA products by the naked eye.
| MATERIAL S AND ME THODS

| Mtb DNA samples
A total of 170 genomic DNA samples extracted from Mycobacterium colonies were used in this study. 
| IS6110 and IS1081 amplifications by conventional PCR
The IS6110 and IS1081 genes were amplified by conventional PCR using specific primers, as summarized in 
| RPA amplification
All 170 samples of Mtb DNA were amplified by the RPA assay targeting the IS6110 and IS1081 genes. The RPA specific primers used in this study are summarized in Table 1 , and Mtb H37Rv genomic DNA and sterile distilled water were used as positive and negative controls, 
| Agarose gel electrophoresis
RPA products (25 μL) were purified by FavorPrep Gel/PCR Purification (Favorgen Biotech Corp., Ping-Tung, Taiwan). The purified RPA products were visualized via 1.5% agarose gel electrophoresis containing UltraPower DNA/RNA Safedye (Gellex) under UV light. Amplifications of IS6110 and IS1081 were expected to generate visible bands of 416 and 238 bp, respectively, on the agarose gel.
A 100-bp DNA ladder was used as the molecular marker.
| SYBR green I detection
Amplified IS6110 and IS1081 RPA products were directly detected by the naked eye in the natural light by adding 1 μL of 375x SYBR Green I (TaKaRa Bio, Tokyo, Japan) to the 25-μL RPA product tube and immediately observing a color change of the solution. The solution changed from light orange to bright green in the presence of RPA amplicons, implying that Mtb DNA was detected. By contrast, the solution remained light orange in the absence of RPA amplification, indicating that Mtb DNA was not detected. RPA coupled with SYBR Green I detection was blindly interpreted to eliminate bias.
| Limit of detection determination
To determine the limit of detection (LOD) of the RPA assay, genomic DNA extracted from Mtb H37Rv was tenfold serially diluted from 5 to 0.00005 ng and used as a template for each pair of primer sets for amplification. Sterile distilled water was used as a negative control. After amplification, each reaction was aliquoted for SYBR Green I detection and compared to 1.5% agarose gel electrophoresis detection. 
| Specificity testing
| RE SULTS
| PCR amplifications
| RPA amplification
Amplification by RPA generated IS6110 (423 bp) and IS1081
(173 bp) products. To detect RPA products of the 146 Mtb and 24 NTM genomic DNA samples, two different DNA product analyses were applied. For RPA-AGE, the purified RPA products were analyzed by 1.5% agarose gel electrophoresis ( Figure 1 ). All of the 146 Mtb strains, but not the NTM strains, were able to be detected by RPA-AGE using both the IS6110 and IS1081 targets. The rest of nonpurified RPA products were directly added to 1 μL of 375x SYBR Green I, and an immediate color change of the solution was observed by the naked eye. orange color solution indicates a negative result (Mtb DNA was not detected). RPA-S was able to detect 143 Mtb strains using the IS6110 target and 145 Mtb strains using the IS1081 target. Three samples for the IS6110 target and one sample for the IS1081 target gave indefinite results; borderline orange-green colors observed for RPA-S using IS6110 and IS1081 as the targets, respectively.
However, in this study, IS6110 and IS1081 were able to differentiate NTM from Mtb. None of the NTM strains were able to be detected by either RPA-AGE or RPA-S. The RPA amplifications for each target are summarized in Table 3 .
| Performance of RPA
Among these 170 samples, compared to conventional PCR, the sensitivity and specificity of the IS6110 RPA-AGE assay were 100% TA B L E 3 Mycobacterium strains detected by RPA-AGE and RPA-S
| LOD of RPA-AGE and RPA-S
A limit of detection was determined according to the lowest DNA concentration that could be detected by either RPA-AGE or RPA-S.
The LODs of RPA-AGE were found to be 100 and 1000 times lower than those RPA-S when targeting IS6110 and IS1081, respectively.
When using the IS1081 primers, only 0.00005 and 0.05 ng of Mtb H37Rv DNA were required for the RPA-AGE and RPA-S reactions, respectively, to be positive. However, when using the IS6110 primers, 0.005 and 0.5 ng of the DNA templates were required for RPA-AGE and RPA-S reactions, respectively, to be consistently positive.
IS1081 was found to be the more sensitive target compared to IS6110 in this study.
| Specificity of RPA
The specificity of the RPA assay was assessed for both target se- by RPA-AGE and RPA-S. Neither assay detected DNA from these bacteria. Figure 3 shows the detection of RPA products of IS1081
(data not shown for IS6110 detection).
| D ISCUSS I ON
TB is a global healthcare concern worldwide due to its high mortality and morbidity. A rapid, accurate diagnosis and promptly appropriate treatment could be effective for decreasing death rates and disease transmission. Sputum microscopy is a frontline diagnostic test for TB used in developing countries, particularly in low-resource and peripheral healthcare settings. However, the low sensitivity of sputum microscopy endangers the control of TB diseases. 26 Isolation of M. tuberculosis, the causative agent of TB, is the most sensitive diagnostic method, but it is time-consuming and requires sophisticated laboratory facilities. 15 Despite the fact that nucleic acid amplification-based diagnosis enables sensitive detection of TB at low density with a rapid turnaround time, the utility of current conventional and commercial amplification methods is limited by their costs and complexity. 15 Recombinase polymerase amplification is a promising isothermal molecular tool that has been increasingly used in clinical microbiology laboratories because it has a simple, affordable, rapid, and sensitive method for identifying pathogens. 20 Recently, RPA has been developed to detect Mtb DNA in combination with a variety of detection formats, including a fluorescence detection device 24 and bridging flocculation. 25 However, specific or electrical instruments are still required for these detection formats. Here, we attempted to develop RPA combined with SYBR Green I to obtain instrumentfree nucleic acid amplification and detection for Mtb diagnosis. With the RPA system, the manufacturer recommends general guidelines for designing RPA primers for a successful amplification. 32 These include avoiding long tracks of one particular nucleotide, especially guanine, or a large number of small repeats at the 5′ terminus. GC content higher than 70% or lower than 30% must be avoided. RPA primers should be 30-35 bases long, while more extended primer over 45 bases are not recommended because they are like to form the secondary structures. 32 In our study, two to three forward and reverse primers for each specific sequence (IS6110 and IS1081) were designed. These RPA primer candidates contained 29-30 bases and had GC content ranging from 56% to 62%. All primer candidates were analyzed for a possibility to form secondary structure (such as hairpin loop and self-dimer) using Compared to conventional PCR, the RPA technique demonstrated a good capability to amplify Mtb DNA using IS6110
and IS1081 as targets. All of the Mtb isolates were correctly differentiated from NTM isolates via RPA-AGE (100% sensitivity and specificity for either IS6110 or IS1081 targets). Our study showed that RPA-S had reduced sensitivity to detect Mtb via either IS6110 (97.95% sensitivity) or IS1081 (99.32% sensitivity); however, it still had 100% specificity for both targets. There were 3 (for IS6110) and 1 (for IS1081) RPA-S reactions that exhibited an indefinite orange-green color after adding SYBR Green I, which were interpreted as negative for Mtb detection. A previous study
showed that there was no significant difference between the LAMP results detected by agarose gel electrophoresis or naked eye detection of LAMP products after SYBR Green I addition. 34 Although SYBR Green I exhibits good sensitivity for DNA detection, false negatives somehow occur when the DNA content is low. 35 DNA from 300 ng to 2 μg has been suggested to be used as the template amount for amplification, followed by the detection by SYBR Green I; otherwise, the experimental results cannot be visualized by the naked eye. 36 In our RPA-S assay, the final amount of template DNA used was only 0.1 ng, which may have led to the false negatives observed in the four negative RPA-S reactions mentioned above. Despite the disadvantages of SYBR Green I, such as extensive optimization or preferential binding to certain DNA sequences, 37 it remains one of the most widely used dyes for nonspecific DNA detection due to its cost efficiency and easy setup. 38 Our RPA assay targeted two different insertion sequences that are highly specific for Mtb, IS6110 and IS1081. In this study, RPA-AGE and RPA-S showed satisfying diagnostic specificity, with no cross-reaction with other bacterial genera or species. While IS6110 is present in Mtb at a copy number of up to 25 per genome and has high sensitivity for Mtb diagnosis by PCR, 39 Mycobacterium tuberculosis complex isolates with no IS6110 have been reported. 40 On the contrary, IS1081 is present in all MTBC species, with a stable copy number of 5-7 repeats per genome. 41 When testing with IS1081, RPA-AGE and RPA-S were able to detect Mtb DNA as low as 0.00005 ng and 0.05 ng, respectively. However, IS6110 required a slightly higher amount of DNA 0.005 ng and 0.5 ng for the RPA-AGE and RPA-S assays, respectively. The DNA product length has been shown to impact the LOD of SYBR Green I. The optimal DNA product length recommended for SYBR Green I detection is generally less than 200 bp. 33 Amplification of IS6110 by RPA generated products of 423 bp, which is larger than IS1081, which is173 bp. The reduced LOD of IS6110 RPA-S may be due to the loss of efficiency of SYBR Green I when detecting the longer product.
The different LODs between RPA-AGE and RPA-S may be due to the efficiency of the dye used in the individual system. In the RPA-AGE assay, the UltraPower DNA/RNA fluorescent dye was used to detect RPA amplicons when electroporated, and it is able to detect at least 20 pg of double-stranded DNA in an agarose gel. 42 SYBR Green I was used to detect RPA amplicons in the RPA-S assay. However, SYBR Green I also has a high sensitivity for double-stranded DNA detection, as low as 60 pg, when coupled with agarose gel electrophoresis with visualization via an UV transilluminator. 43 In our study, the RPA-S reaction was observed for a SYBR Green I color change; this change was observed by the naked eye. This detection method probably limits the efficiency of SYBR Green I when performing the LOD test via RPA-S compared with RPA-AGE in this study.
Conforming to a previous study that provided evidence for using RPA as a tool for the rapid and sensitive detection of DNA from Mtb, 24 our developed RPA-S assay provides a rapid (~15-20 min from sampling to readout), sensitive (0.5-0.05 ng for LOD), convenient molecular method for Mtb detection at an affordable price (~5 USD per reaction). Moreover, RPA-S does not require expensive or specific laboratory devices, making it a possible candidate for development as a point-of-care diagnostic device for TB infection in future. Although a rapid amplification is now available, extraction of nucleic acid from direct specimens remains a laboratory-based practice. Adoption of DNA tests at the point-of-care setting still requires the development of simplified sample-handling procedures.
In conclusion, our study demonstrates the application of SYBR Green I with the RPA assay for Mtb detection by the naked eye. This assay can be implemented as an alternative molecular diagnostic test for the screening of TB infection, which could help control the spread of TB, especially in low-resource and peripheral healthcare settings.
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